Haemonetics is a leading global healthcare company (NYSE: HAE) founded in 1971. It is dedicated to providing innovative medical products and solutions in the biotechnology and healthcare industries, aimed at improving patient care and reducing healthcare costs. The company's focus areas include blood and plasma component collection, the surgical suite, and hospital transfusion services. Haemonetics recently secured a $600.00M Post-IPO Debt investment on 21 May 2024. For more information about Haemonetics, visit www.haemonetics.com.
Haemonetics
We make it possible. You make it matter.
Founded 1971
Boston, United States
2511 employees
Post Ipo Debt
Total: $1.75B
Biotechnology, Health Care +1
Boston, United States
2511 employees
Post Ipo Debt
Total: $1.75B
Biotechnology, Health Care +1
General Information
Get notified when Haemonetics moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Haemonetics
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About Haemonetics
Taxonomy: medical products, blood processing technology, surgical blood salvage, diagnostic products, information technology, consulting services, interventional technologies, plasma collection, blood collection, healthcare cost reduction, global company, innovation, medical markets
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Debt | •••••• | - | 21 May 2024 | |
| Post-IPO Equity | •••••• | - | 01 Mar 2021 | |
| Post-IPO Equity | •••••• | - | 23 May 2019 | |
| Post-IPO Debt | •••••• | - | 18 Jun 2018 |
Haemonetics Alternatives & Competitors
Haemonetics vs
Terumo Cardiovascular
United States
Our mission is to work as a team to save one more life, today and every day.
777 employees
Biotechnology, Design
Haemonetics vs
Blood Bank of Alaska
United States
Providing essential blood services while ensuring donor eligibility through personalized assistance...
60 employees
Health Care, Pharmaceutical
Haemonetics vs
Kurin Inc.
United States
Reshaping Blood Culture Collection Standard of Care
Series Unknown
82 employees
Health Care
FAQ About Haemonetics
We make it possible. You make it matter.
Haemonetics was founded in 1971.
Haemonetics is headquartered in Boston, United States.
Haemonetics operates in the following industries: Biotechnology, Health Care, Medical Devices.
Haemonetics has approximately 2511 employees.
Haemonetics has completed 4 funding rounds, raising a total of $1.75B. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Haemonetics include Terumo Cardiovascular, Blood Bank of Alaska, Kurin Inc., LifeShare Blood Center, Loop Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Haemonetics and Terumo Cardiovascular are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Haemonetics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
